KKR to Acquire PRA International
PRA International(?PRA?), a leading clinical research organization,today announced that funds managed by KKR, a leading global investment firm, are acquiring PRA from Genstar Capital, LLC (?Genstar?), a private equity firm based in San Francisco.
PRA International (“PRA”), a clinical research organization, today announced that funds managed by KKR, a global investment firm, are acquiring PRA from Genstar Capital, LLC (“Genstar”), a private equity firm based in San Francisco. PRA is a global contract research organizations (“CRO”), providing outsourced clinical development services to the biotechnology and pharmaceutical industries.
PRA hasmore than 5,300 employees located in over 50 offices worldwide. Since 2000, PRA has performed approximately 2,000 clinicaltrialsin over 80 countries on behalf of over 300 clients.
“PRA is a well‐positioned global CRO platform led by a talented management team with a long track record of success. As one of the fastest growing companies in the CRO sector, PRA is known for its strong client relationships and differentiated therapeutic expertise. PRA management and KKR share the common ambition of building on this platform by continually improving service offerings to clients and providing compelling career opportunities for employees,” said Jim Momtazee, Member of KKR and Head of KKR’s Health Care investing team.
“This transaction marks the next stage of our evolution. With KKR as our new partner, we look forward to working with them to accelerate our innovation and growth while continuing to make a difference not only for our clients but also for our people,” said Colin Shannon, President and Chief Executive Officer of PRA.
The transaction, which is subject to regulatory approvals and other customary closing conditions, is expected to close in the third quarter of 2013.
Jefferies LLC acted as exclusive financial advisor and Latham & Watkins acted as legal advisor to PRA. Credit Suisse,UBS Investment Bank, and Wells Fargo Securities, LLC served as financial advisors to KKR. Simpson Thacher & Bartlett LLP served as legal counsel to KKR. Fully committed debt financing will be provided by Credit Suisse, Jefferies, UBS Investment Bank, and KKR Capital Markets.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
